Description

4-[6-Ethoxy-3a,4,5,6,6a,7-hexahydro-8-hydroxy-3,3,11,11-tetramethyl-13-(3-methyl-2-butenyl)-7,15-dioxo-1,5-methano-3H,11H-furo[3,4-g]pyrano[3,2-b]xanthen-1-yl]-2-methyl-2-butenal is a complex, high-purity organic compound belonging to the xanthone derivative family, valued for its intricate molecular architecture. This compound is critical for advanced research and development in the pharmaceutical and fine chemical sectors, where precise molecular structures are required. It serves as a key intermediate or reference standard for scientists developing novel therapeutic agents, particularly in oncology and anti-inflammatory drug discovery.

Application

• Pharmaceutical Intermediate: Serves as a crucial building block in the synthesis of novel drug candidates, especially those targeting specific biological pathways.
• Reference Standard: Used in analytical laboratories for method development, validation, and quality control of related active pharmaceutical ingredients (APIs).
• Biochemical Research: Employed in life science research to study enzyme inhibition, receptor binding, and other molecular interactions due to its specific xanthone-based structure.
• Fine Chemical Synthesis: Acts as a specialized precursor for creating complex molecules with potential applications in material science and agrochemicals.
• Academic Research: Utilized in university and institutional labs for synthetic chemistry studies and the exploration of new heterocyclic compound libraries.

Basic Information

Product Name	4-[6-Ethoxy-3a,4,5,6,6a,7-hexahydro-8-hydroxy-3,3,11,11-tetramethyl-13-(3-methyl-2-butenyl)-7,15-dioxo-1,5-methano-3H,11H-furo[3,4-g]pyrano[3,2-b]xanthen-1-yl]-2-methyl-2-butenal
CAS No.	55221-73-3
Molecular Formula	C₃₄H₄₀O₈
Molecular Weight	576.68 g/mol
Synonyms	Gambogic acid derivative; 13-Isogambogylbutenal; Gambogic acid butenal; 1-(4,6-Dihydro-8-hydroxy-3,3,11,11-tetramethyl-7,15-dioxo-13-(3-methyl-2-butenyl)-1,5-methanofuro[3,4-g]pyrano[3,2-b]xanthen-1-yl)-2-methyl-2-buten-1-one, 6-ethoxy-3a,4,5,6,6a,7-hexahydro-; 4-[6-Ethoxy-3a,4,5,6,6a,7-hexahydro-8-hydroxy-3,3,11,11-tetramethyl-13-(3-methylbut-2-en-1-yl)-7,15-dioxo-1,5-methano-3H,11H-furo[3,4-g]pyrano[3,2-b]xanthen-1-yl]-2-methylbut-2-enal
EINECS	Contact for details

Quality Control

Our production of 4-[6-Ethoxy-3a,4,5,6,6a,7-hexahydro-8-hydroxy-3,3,11,11-tetramethyl-13-(3-methyl-2-butenyl)-7,15-dioxo-1,5-methano-3H,11H-furo[3,4-g]pyrano[3,2-b]xanthen-1-yl]-2-methyl-2-butenal adheres to stringent quality management systems. The compound undergoes rigorous analytical testing, including HPLC, NMR, and MS, to ensure identity, purity, and consistency. A comprehensive Certificate of Analysis (COA) detailing all specifications is provided with each batch, supporting compliance in GMP-aligned research and development environments.

Storage

Preserve in a tightly closed container, protected from light. Store at controlled room temperature (15-25°C) or as indicated on the label or COA. For long-term storage, consider storing under inert atmosphere to preserve stability. Keep container tightly sealed in a dry and well-ventilated place.

Specification

Item	Specification
Appearance	Yellow to orange powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥ 95.0%
Related Substances (HPLC)	Total impurities ≤ 5.0% Any single impurity ≤ 2.0%
Residual Solvents (GC)	Complies with ICH guidelines
Loss on Drying	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.